Back

Mapping the phenotypic spectrum of transthyretin amyloid cardiomyopathy using a multidomain red flag scoring system

30 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: New insights into cardiac amyloidosis Infiltrative Myocardial Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Freideriki Eleni Kourti

National & Kapodistrian University of Athens Medical School, Athens (Greece)

7 More presentations in this session

Presentation thumbnail
Decoding peripartum cardiomyopathy through multi-omics: circulating and cellular signatures from the Italian multicenter registry
Doctor M. Carotenuto (Naples, IT)
Abstract Slides Video
Presentation thumbnail
Premature hypertensive heart disease in working-age adults: global burden, inequalities and missed prevention opportunities (GBD 2021)
Doctor X. Dong (Beijing, CN)
Presentation thumbnail
Vascular dysfunction is associated with symptom severity and quality of life in wild-type transthyretin amyloid cardiomyopathy
Mr N. Ogasawara (Akita, JP)
Abstract Slides Video
Presentation thumbnail
Diagnostic utility of three clinical scoring systems for transthyretin amyloid cardiomyopathy in elderly Asian patients with heart failure with preserved ejection fraction
Doctor M. Chen (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Improvement of health status with acoramidis in patients with wild-type and variant transthyretin amyloid cardiomyopathy: KCCQ domains analysis from the ATTRibute-CM study
Doctor N. Sarswat (Chicago, US)
Abstract Slides Video

Access the full session

Session thumbnail
New insights into cardiac amyloidosis

The Event

Event poster

ESC Congress 2026

30 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Neurological and cardiological profiling of patients with mutated transthyretin amyloidosis
31 August 2025
thumbnail
Congress Presentation
Comparative diagnostic performance of clinical scores for transthyretin amyloid cardiomyopathy across disease stages
28 August 2026
thumbnail
Congress Presentation
Clinical outcomes and treatment response according to ATTR-CM risk in HFpEF: a real-world cohort study
29 August 2026
thumbnail
Congress Presentation
Imaging-guided risk stratification in transthyretin amyloidosis
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources